Serum Lenvatinib Concentration Monitoring in a Patient With Thyroid Cancer Exhibiting Hand-Foot Syndrome
This case's findings suggest that serum lenvatinib concentrations are associated with the severity of lenvatinib-induced HFS and that there may be an overlap between drug concentrations, metastatic suppression, and the grade of HFS.
Authors
- Kosuke Doki (ORCID: https://orcid.org/0000-0003-2497-0063)
- Ikuo Sekine (ORCID: https://orcid.org/0000-0003-1105-7339)
- Masato Homma (ORCID: https://orcid.org/0000-0002-4824-3242)
- Hisato Hara (ORCID: https://orcid.org/0000-0002-2764-0353)
- Yusuke Watanabe
Institutions
- University of Tsukuba (JP)
- University of Tsukuba Hospital (JP)
Publication Details
- Journal
- Therapeutic Drug Monitoring
- Published
- 2025-02-28
- DOI
- https://doi.org/10.1097/ftd.0000000000001312
- Primary Topic
- Chemotherapy-related skin toxicity
- Type
- article
- Field-Weighted Citation Impact
- 0.00